Skip to main content
. 2020 Jul 24;125(4):481–483. doi: 10.1016/j.anai.2020.07.023

Table 1.

Preexisting Conditions and COVID-19–related Outcomes in 949 COVID-19 Patients in Association With Smell Loss

Conditions Number of cases with condition among the series Odds ratio (95% CI) of having smell loss in patients with the condition compared with those without the condition Adjusted P valuea
History of smell dysfunction 27 4.66 (2.07-10.46) <.001b
Allergic rhinitis 101 1.79 (1.12-2.87) .02c
Food allergy 71 1.64 (0.95- 2.83) .08
Atopic dermatitis (eczema) 42 1.22 (0.59-2.50) .60
Asthma 243 1.18 (0.82-1.70) .36
Chronic rhinosinusitis 15 3.70 (1.29-10.67) .02c
GERD 60 0.67 (0.29-1.58) .36
Diabetes 243 0.86 (0.57-1.29) .46
Hypertension 391 1.14 (0.77-1.68) .52
Emergency department visit for COVID-19 520 0.83 (0.59-1.16) .28
Hospitalized 311 0.69 (0.47-0.99) .04c
ICU-admitted 131 0.38 (0.20-0.70) .002c
Intubated 86 0.43 (0.21-0.89) .02c
ARDS 93 0.45 (0.23-0.89) .02c

Abbreviations: ARDS, acute respiratory distress syndrome; BMI, body mass index; COVID-19, coronavirus disease 2019; GERD, gastroesophageal reflux disease; ICU, intensive care unit.

a

Odds ratios and adjusted P values are calculated by logistic regression adjusting for age, sex, and BMI.

b

P value less than .001.

c

P value less than .05.